ACT Biotech
Latest round
- Series A
Last raised
- May 2008
Total raised
- $6.6M
Investors
- 1
About ACT Biotech
Established in 2008, ACT Biotech operates in the biotechnology sector, focusing on innovative solutions for health challenges.ACT Biotech is primarily engaged in the biotechnology sector, focusing on the development and provision of innovative biotechnology solutions aimed at enhancing health outcomes. The company’s core product offerings revolve around advanced biotechnological applications that address critical challenges in health, including drug development, genetic research, and personalized medicine. ACT Biotech's products are designed to serve a diverse clientele, including research institutions, pharmaceutical companies, and healthcare providers, who utilize these solutions to improve patient care and streamline research processes.The revenue model for ACT Biotech is structured around a combination of direct sales and strategic partnerships with healthcare organizations and research institutions. The company typically engages in B2B transactions, providing its biotechnology products and services through tailored agreements that meet the specific needs of its clients. For example, it may offer subscription-based access to its proprietary technology platforms or enter into collaborative research agreements that involve milestone payments contingent upon the achievement of specific project goals. Pricing structures for these transactions are designed to reflect the value and innovation of the products offered, with services potentially including long-term contracts or one-time licensing fees for flagship products. ACT Biotech aims to launch new biotechnology solutions specifically designed to address unmet needs in personalized medicine by the end of 2011. Additionally, the company has targeted expansion into new markets, focusing on Asia and Europe, by 2012, to broaden its reach in the global biotechnology landscape.
Who invested in ACT Biotech
1 investor across 1 round
See all investors in ACT Biotech
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
May 6, 2008
Amount
$6.6M
Investors
Questions about ACT Biotech
Who invested in ACT Biotech?
ACT Biotech has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has ACT Biotech raised?
ACT Biotech has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did ACT Biotech last raise money?
ACT Biotech's most recent round on record is a Series A, in May 2008.
What does ACT Biotech do?
Established in 2008, ACT Biotech operates in the biotechnology sector, focusing on innovative solutions for health challenges.
Where is ACT Biotech headquartered?
ACT Biotech is headquartered in San Francisco, US.
Which VCs invest in companies like ACT Biotech?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at ACT Biotech's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like ACT Biotech? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.